Genotyping and cancer gene mutation detection is performed by the high throughput benchtop Mass ARRAY platform (https://agenabio.com/products/massarray-system/ ). The system is based on MALDI-TOF mass spectrometry, a non-fluorescent detection platform utilizing mass spectrometry to accurately measure highly multiplexed PCR-derived amplicons within a working day.The system works with standard 96-well plates and is unique in Greece. It combines mass spectrometry, sensitive and robust chemistry, and advanced data analysis software providing accurate analysis of clinically relevant mutations in a single workflow. Applications may include tumor profiling, hereditary genetic and pharmacogenetic testing.